How should the ingredient list be formatted for U.S. labels for private label eye care?

For U.S. cosmetic eye care labels, list ingredients using INCI names under "Ingredients:" in descending order of predominance. If the product is OTC (for example, drug or sunscreen claims), use a Drug Facts panel with Active/Inactive ingredients instead.

US buyer view Launch planning Updated: January 27, 2026
Chat on WhatsApp
Best for
US brand owners, Amazon/FBA sellers, distributors, and private label buyers
Core intent
Who submits, what data is needed, and how to plan timelines before production

Quick Answer (for busy buyers)

Here’s the buyer-first summary. If your brand name is on the label, you usually act as the responsible person and must ensure the listing is submitted and kept current.

  • For U.S. cosmetic eye care (eye cream, eye gel, eye serum), format the ingredient declaration as: “Ingredients:” followed by INCI names.
  • List ingredients present at more than 1% in descending order; ingredients at 1% or less may be listed in any order after those.
  • Color additives are typically listed at the end, and fragrance can appear as “Fragrance” (or “Parfum”).
  • Use English, keep it legible (commonly at least 1/16 inch type, unless the pack is very small), and place it on the outer container (carton), with the jar/tube if space allows.
  • If your eye care is OTC in the U.S. (for example, SPF or drug active claims), the format changes to Drug Facts, with Active ingredients (with %), Purpose, Uses, Warnings, Directions, and Inactive ingredients.
  • We will confirm your intended claims early so your label structure matches the correct category.
  • On the OEM/ODM side, we can provide customized formulas and lab samples (usually 1 to 2 rounds), help prepare label-ready INCI lists, and support documentation and testing (for example, GMP/ISO manufacturing docs, product test reports, and barcode/packaging artwork coordination).
  • MOQ and lead time depend on formula and packaging; we support small-batch starts and scale-up on automated lines once the final sample and packaging are approved.
Buyer outcome
A launch-ready compliance plan: inputs collected, roles assigned, and update cadence defined.
Most common blocker
Missing facility information + inconsistent ingredient/label snapshots across SKUs.
⚠️
This page is a practical buyer guide. For definitive requirements and updates, use FDA resources and qualified regulatory counsel.
  • Our team will answer your inquiries within 8 hours.
  • Your information will be kept strictly confidential.

Request received

Thanks — we’ve received your request. Our team will follow up shortly. we typically reply within 8 hours (often sooner).